Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 416 of 1,261
  1. US 10688195

    Polymyxin B-coated nanoparticles

    Northwestern University · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  2. US 10688183

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  3. US 10688185

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  4. US 10688203

    Methods of performing brachytherapy

    The Board of Regents of the University of Texas System · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  5. US 10688174

    Method of conferring a protective immune response to norovirus

    Takeda Vaccines, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  6. US 10688453

    System and method for droplet formation and manipulation using ferrofluids

    The Regents of the University of California · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  7. US 10688099

    Methods for modulating the amount of RNA transcripts

    PTC THERAPEUTICS, INC. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  8. US 10688172

    HPV particles and uses thereof

    Aura Biosciences, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  9. US 10688080

    Compositions, methods of use, and methods of treatment

    The Regents of the University of California · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  10. US 10688056

    Implantable medical devices for extended release of therapeutic agents

    Nano Precision Medical, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  11. US 10688090

    Vilazodone inclusion complexes, compositions and preparation thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  12. US 10688063

    Treating and/or preventing insulin-resistance related weight gain

    The United States Government as Represented by the Department of Veterans Affairs of General Counsel- PSG IV (024) · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  13. US 10683530

    Detection of oligosaccharides

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  14. US 10683504

    Serpina1 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  15. US 10683503

    Antisense oligomers for treatment of conditions and diseases

    STOKE THERAPEUTICS, INC. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  16. US 10683366

    Methods and compositions for treatment of atherosclerosis

    The Board of Regents of the University of Texas System · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  17. US 10682368

    Methods of treating feline coronavirus infections

    The Regents of the University of California · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  18. US 10683500

    UNA oligomers having reduced off-target effects in gene silencing

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  19. US 10683499

    Compositions and methods for modulating TTR expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  20. US 10683501

    Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

    Alnylam Pharmaceuticals, Inc. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  21. US 10683354

    Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  22. US 10683316

    Synthetic catalase/superoxide dismutase mimetics and methods for treating viral infections

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  23. US 10683330

    Campylobacter immunogenic compositions and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  24. US 10683283

    Substituted ureas and methods of making and using same

    Mebias Discovery, Inc. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.